GENETIC COUNSELING: BRIDGING SCIENCE & PATIENT CARE

"𝓐𝓼 𝔀𝓮 𝓽𝓮𝓼𝓽 𝓶𝓸𝓻𝓮, 𝔀𝓮 𝓶𝓾𝓼𝓽 𝓬𝓸𝓾𝓷𝓼𝓮𝓵 𝓫𝓮𝓽𝓽𝓮𝓻; 𝓫𝓮𝓬𝓪𝓾𝓼𝓮 𝓰𝓮𝓷𝓮𝓽𝓲𝓬 𝓴𝓷𝓸𝔀𝓵𝓮𝓭𝓰𝓮 𝔀𝓲𝓽𝓱𝓸𝓾𝓽 𝓼𝓾𝓹𝓹𝓸𝓻𝓽 𝓬𝓪𝓷 𝓸𝓿𝓮𝓻𝔀𝓱𝓮𝓵𝓶 𝓻𝓪𝓽𝓱𝓮𝓻 𝓽𝓱𝓪𝓷 𝓮𝓶𝓹𝓸𝔀𝓮𝓻." — Laura Hercher

🧬 Breakthroughs in genetics are transforming healthcare, and at the heart of this shift is genetic counseling, where science meets patient care. Genetic counselors translate complex data into clear, compassionate guidance, empowering individuals and families to make informed decisions about their health.
          🔹 At its core, genetic counseling is communication. It’s about educating people on risks, testing options, and outcomes while creating space for their fears, hopes, and questions. Whether it’s hereditary cancer, Infertility, rare diseases, or family planning, counselors help patients navigate choices with confidence.
          🔹 The impact? Early detection, personalized care, and better outcomes. Beyond the clinic, genetic counselors addresses emotional tolls, connect patients to resources, and advocate for their well-being; blending expertise with empathy.
          🔹 As the field grows, so do ethical challenges: privacy, discrimination, and cultural sensitivity. Counselors play a vital role in ensuring genetic knowledge is empowering, not overwhelming; upholding ethics while respecting diverse beliefs.

⚠️ In an oystershell, genetic counseling bridges cutting-edge science with human care. As precision medicine advances, the role of genetic counselors remain very vital; guiding informed choices, supporting mental well-being, and ensuring genetics serves patients meaningfully and ethically.

Abubakar Abubakar ✍🏻

• Bombard, Y., Brothers, K. B., Fitzgerald-Butt, S., & McCormick, J. B. (2019). American Journal of Human Genetics, 104(4), 559-564.

• Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). New England Journal of Medicine, 364(6), 524-534.

• Middleton, A., Morley, K. I., Bragin, E., Firth, H. V., Hurles, M. E., Wright, C. F., & Parker, M. (2015).
European Journal of Human Genetics, 24(1), 21-29.

• Kaphingst, K. A., Facio, F. M., Cheng, M. R., Brooks, S., Eidem, H., Linn, A., ... & Biesecker, B. B. (2012). Clinical Genetics, 82(5), 408-415.

• Resta, R. G., Biesecker, B. B., Bennett, R. L., Blum, S., Hahn, S. E., Strecker, M. N., & Williams, J. L. (2006). Journal of Genetic Counseling, 15(2), 77-83.

• Hooker, G. W., Leventhal, K. G., DeMarco, T. A., Uhlmann, W. R., & Green, R. C. (2017). Journal of Community Genetics, 8(3), 189-197.

#PatientCare #Genetics #GeneticCounseling #PrecisionMedicine #GeneticTesting #DNA #IVF #Genomics #HereditaryHealth #NGS #CRISPR #HealthCare 🩺

Popular posts from this blog

FINDING LAUGHTER IN UNEXPECTED MOMENTS: A LESSON IN BEING PREPARED

Image
Today's blog is about an experience I had while visiting a religious site on the outskirts of town. As I was leaving, a lady approached me, asking for a donation. Unfortunately, I wasn’t carrying any cash at the time, so I asked her, "Do you use UPI by any chance?" She burst into laughter 😄, smiling at my unexpected question. The lesson here is that we should always be prepared with alternatives, as they might be a way to help others.  At the very least, I managed to put a smile on her face, which made the encounter worthwhile 😊
Read more

CHROMOSOMAL MICROARRAY VS. WHOLE EXOME SEQUENCING

Image
“𝓜𝓲𝓬𝓻𝓸𝓪𝓻𝓻𝓪𝔂𝓼 𝓱𝓮𝓵𝓹 𝓾𝓼 𝓯𝓲𝓷𝓭 𝓶𝓲𝓼𝓼𝓲𝓷𝓰 𝓸𝓻 𝓮𝔁𝓽𝓻𝓪 𝓬𝓱𝓻𝓸𝓶𝓸𝓼𝓸𝓶𝓪𝓵 𝓹𝓲𝓮𝓬𝓮𝓼; 𝓦𝓔𝓢 𝓽𝓪𝓴𝓮𝓼 𝓾𝓼 𝓭𝓮𝓮𝓹𝓮𝓻, 𝓲𝓷𝓽𝓸 𝓽𝓱𝓮 𝓬𝓸𝓭𝓲𝓷𝓰 𝓻𝓮𝓰𝓲𝓸𝓷𝓼 𝔀𝓱𝓮𝓻𝓮 𝓻𝓪𝓻𝓮 𝓿𝓪𝓻𝓲𝓪𝓷𝓽𝓼 𝓱𝓲𝓭𝓮.” — Ellen Matloff 🧬 Chromosomal Microarray (CMA) and Whole Exome Sequencing (WES) are cornerstones of modern genomic diagnostics. Each offers unique insights: CMA identifies large-scale structural changes like copy number variations (CNVs), while WES investigates the exome; the protein-coding portion where most pathogenic mutations reside. 🔹 CMA is a first-line tool for neurodevelopmental disorders, intellectual disability, and congenital anomalies. It scans for chromosomal imbalances missed by karyotyping, offering ~15–20% diagnostic yield in such cases. Its speed and cost-effectiveness make it a go-to for initial evaluations. 🔹 WES, by contrast, dives into the exonic 1–2% of the genome that harbors ~85% of known disease-causing ...
Read more